TPI 287
Showing 1 - 25 of 73
Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)
Terminated
- Neuroblastoma
- Medulloblastoma
- TPI 287
-
San Diego, California
- +7 more
Apr 20, 2022
Brain Metastases, Generalized Malignancy, Primary, Brain Lesions Trial in Tampa (TPI 287, Fractionated Stereotactic Radiotherapy
Terminated
- Brain Metastases
- +2 more
- TPI 287
- Fractionated Stereotactic Radiotherapy (FSRT)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Feb 3, 2021
Alzheimer's Disease Trial in San Francisco (TPI-287 2 mg/m2, TPI-287 6.3 mg/m2, TPI-287 20 mg/m2)
Completed
- Alzheimer's Disease
- TPI-287 2 mg/m2
- +3 more
-
San Francisco, CaliforniaUCSF Memory and Aging Center
Apr 13, 2020
Primary Four Repeat Tauopathies (4RT), Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy (PSP) Trial in Birmingham,
Completed
- Primary Four Repeat Tauopathies (4RT)
- +3 more
- TPI 287 2 mg/m2
- +3 more
-
Birmingham, Alabama
- +1 more
Apr 13, 2020
Brain Tumors, CNS Tumors Trial in Houston (TPI287, Bevacizumab)
Terminated
- Brain Neoplasms
- Central Nervous System Neoplasms
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 14, 2019
Breast Cancer Trial in Houston (TPI 287, Dexamethasone, Benadryl)
Completed
- Breast Cancer
- TPI 287
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 18, 2018
Maternal Psychological Distress, Childhood Trauma, Health Behavior Trial (Trauma Informed Prenatal Intervention (TPI), Prenatal
Not yet recruiting
- Maternal Psychological Distress
- +2 more
- Trauma Informed Prenatal Intervention (TPI)
- Prenatal Education Topics
- (no location specified)
Feb 7, 2023
Diabetes, Type 2 Trial in Graz (insulin icodec, Insulin glargine)
Completed
- Diabetes Mellitus, Type 2
- insulin icodec
- Insulin glargine
-
Graz, AustriaNovo Nordisk Investigational Site
Sep 27, 2022
Validation of a Vital Signs Monitoring Wristband
Recruiting
- Coronary Artery Disease
- Continuous measurement of photoplethysmography at the wrist
-
Delft, Zuid Holland, NetherlandsReinier de Graaf Gasthuis
Dec 1, 2022
EEG and Brain Pulsatility to Novel Stimuli (Electro-PulCe)
Completed
- Healthy Volunteers
- Registration
- Auditive oddball task
-
Tours, FrancePaedopsychiatry department, University Hospital, Tours
Jul 18, 2022
Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece
Completed
- Metastatic Colorectal Cancer
-
Heraklion, Crete, Greece
- +7 more
Mar 4, 2022
Cognitive Function, Job Satisfaction and Sleep Quality in
Recruiting
- Factory Workers
- No intervention
-
İzmir, TurkeyIzmir Bakircay University
Mar 25, 2022
Postoperative Pain, Pelvic Organ Prolapse, Trigger Point Injection Trial in Dayton (marcaine and kenalog)
Recruiting
- Postoperative Pain
- +3 more
- marcaine and kenalog
-
Dayton, OhioKettering Health Network
Mar 29, 2022
REmote CArdiac MOnitoring by Corsano CardioWatch 287-2
Not yet recruiting
- Atrial Fibrillation
- +4 more
- Corsano CardioWatch 287-2
- (no location specified)
Jun 2, 2023
Hypoxia Trial in Genk (CardioWatch 287-2)
Completed
- Hypoxia
- CardioWatch 287-2
-
Genk, BelgiumComplementair Medisch Centrum (CMC) Europe
Sep 13, 2022
Diabetes, Type 2 Trial in Neuss (NNC0148-0287sema, Semaglutide, NNC0148-0287)
Completed
- Diabetes Mellitus, Type 2
- NNC0148-0287sema
- +2 more
-
Neuss, GermanyNovo Nordisk Investigational Site
Sep 28, 2021
Diabetes, Type 1 Trial in Neuss (Insulin icodec, IGlar U100)
Completed
- Diabetes Mellitus, Type 1
- Insulin icodec
- IGlar U100
-
Neuss, GermanyNovo Nordisk Investigational Site
Nov 9, 2021
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin glargine U100)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- Insulin glargine U100
-
Walnut Creek, California
- +37 more
Jan 6, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Cemiplimab
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 6, 2022
HR-positive,HER2-negative in Advanced Breast Cancer Trial in Beijing (TQB3616 capsules, TQB3616-matching , Fluvestrin injection)
Recruiting
- HR-positive,HER2-negative in Advanced Breast Cancer
- TQB3616 capsules
- +2 more
-
Beijing, Beijing, China
- +1 more
May 11, 2022
Colorectal Tumors, Trifluridine and Tipiracil, Circulating Tumor DNA Trial in Japan, Taiwan (trifluridine and tipiracil,
Recruiting
- Colorectal Neoplasms
- +2 more
- trifluridine and tipiracil
- Placebo
-
Nagoya, Aichi, Japan
- +38 more
Jan 18, 2022
Terminal Illness, Terminal Cancer Trial in Zürich (music therapy, recording)
Not yet recruiting
- Terminal Illness
- Terminal Cancer
- music therapy
- recording
-
Zürich, ZH, SwitzerlandUniversity Hospital Zurich
Oct 24, 2023